Results Baseline assessment observed no significant
differences between experimental and control groups for
the variables related to outcomes. For the experimental
group, the proportion of subjects with normal HbA1c
increased from 4.5% (3/66) at baseline to 28.6% (19/66)
at week 28 (p<0.001), but there was insignificant
improvement in the control group (3.9% to 11.8%,
p¼0.13). Repeated measure of analysis of variance
showed pronounced improvement in DM self efficacy
scale and BMI among the experimental group with
significant interaction. Dietary behaviours also improved
significantly in the experimental group.
การแปล กรุณารอสักครู่..
